Rahul Khara - 06 Aug 2026 Form 4 Insider Report for Disc Medicine, Inc. (IRON)

Reporting relationship: Chief Legal Officer
Issuer ticker: IRON
Reported as of: 06 Aug 2026
Net transaction value: -$400,000
SEC form: 4
Accepted by SEC: 07 Aug 2026, 17:32:31 UTC
Prior SEC filing: 30 Jun 2026
Source filing: View source filing
Reporting owner signature: By: /s/ Rahul Khara

Key filing fact

Rahul Khara filed Form 4 for Disc Medicine, Inc. (IRON) on 07 Aug 2026.

Key facts

This page summarizes Rahul Khara's Form 4 filing for Disc Medicine, Inc. (IRON).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 07 Aug 2026, 17:32.

Change

Previous filing in this sequence was filed on 30 Jun 2026.
Current net transaction value: -$400,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001951850 Primary reporting owner

Khara Rahul

Relationship: Chief Legal Officer
Address: C/O DISC MEDICINE, INC., 321 ARSENAL STREET, SUITE 101, WATERTOWN
Signature: By: /s/ Rahul Khara
Signature date: 07 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IRON transaction

Common Stock

Options Exercise

Transaction value
Shares: +5,000
Change %: +9.6%
Price: $14.69^*
Shares after: 57,324
Date: 06 Aug 2026
Ownership: Direct
Footnotes: F1, F2

IRON transaction

Common Stock

Sale

Transaction value: $400,000
Shares: -5,000
Change %: -8.7%
Price: $80.00
Shares after: 52,324
Date: 06 Aug 2026
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IRON transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -5,000
Change %: -9.1%
Price: $0.000000^*
Shares after: 49,804
Date: 06 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,000
Exercise price: $14.69
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026.

Footnote F2

Includes 151 shares purchased pursuant to the Disc Medicine, Inc. Amended and Restated 2021 Employee Stock Purchase Plan on July 31, 2026.

Footnote F3

The shares underlying this option are fully vested and exercisable as of the date hereof.